Financial News
Latest News about XCUR
Recent news which mentions XCUR
From Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 10, 2021
From Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
August 10, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Monday
August 09, 2021
From Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
August 06, 2021
From Benzinga
Exicure Shares Interim Cavrotolimod Data From Early-Stage Trial In Solid Tumor Patients
August 05, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 03, 2021
From Benzinga
61 Biggest Movers From Yesterday
August 03, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 02, 2021
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 02, 2021
From Benzinga
From Benzinga
40 Stocks Moving In Monday's Mid-Day Session
August 02, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 02, 2021
From Benzinga
Exicure Stock Surges On Over $1B Option Licensing Pact With Ipsen For Rare Neurodegenerative Disorders
August 02, 2021
From Benzinga
21 Stocks Moving in Monday's Pre-Market Session
August 02, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 27, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
July 08, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.